Conjugated polymers for biomedical applications. Issue 52 (16th June 2022)

• Record Type: Journal Article
• Authors: Lin, Hongrui; Bai, Haotian; Yang, Zhiwen; Shen, Qi; Li, Mingyu; Huang, Yiming; Lv, Fengting; Wang, Shu
• Is Part Of: Chemical communications. Volume 58:Issue 52(2022)
• Page Start: 7232
• Page End: 7244
• Publication Date: 2022-06-16
• Subjects: Chemistry -- Periodicals; 540
• DOI: 10.1039/d2cc02177c
• Languages: English
• ISSNs: 1359-7345

Abstract

Abstract : This review highlighted some latest developments of conjugated polymers (CPs) in biotherapy, biological regulation, biological response and bioprinting applications, and also discussed the referred challenges and outlooks for biomedical applications. Abstract : Conjugated polymers (CPs) are a series of organic semiconductor materials with large π-conjugated backbones and delocalized electronic structures. Due to their specific photophysical properties and photoelectric effects, plenty of CPs with varied chemical structures and functions are quickly evolving in the diverse biomedical field, such as fluorescence imaging, photodynamic therapy, photothermal therapy, etc. In addition, the functionalized side chains of CPs could contribute to the expected water-solubility, biocompatibility, biological response, etc. CPs can also be prepared into nanoparticles for acquiring controllable particle size and dispersion through the common synthesis procedure. In this review, we focus on the latest developments of CPs in biotherapy, biological regulation, biological response and bioprinting applications. The major challenges and outlooks of CPs for applications in the biomedical field are also discussed.